secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inhibikase Therapeutics, Inc. (IKT)
CIK:        0001750149
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0001193125-23-069219
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Inhibikase Therapeutics discloses no exposure to Silicon Valley Bank
--------------------------------------------------------------------

- Company holds no cash deposits or lines of credit with SVB.
- No business relationship with SVB exists.
- Filing aims to reassure investors amid SVB collapse.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750149/000119312523069219/0001193125-23-069219-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750149/000119312523069219/d475007d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-069219

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer